Effectiveness of Delirium Care Protocol After Cardiac Surgery

Status Completed

Clinical Trial Summary

Clinical Trial Description

This study was conducted as a quasi-experimental study to determine the effectiveness of the postoperative delirium prevention, diagnosis and intervention protocol in patients monitored in the intensive care unit after cardiac surgery. The research was conducted at Antalya Training and Research Hospital between 06.03.2023 and 22.05.2023. The sample of the study consisted of 64 patients who underwent cardiac surgery and met the inclusion criteria. Within the scope of the study, patients were divided into two groups: control (32) and intervention (32). While the patients in the intervention group received care in line with the "Postoperative delirium prevention, diagnosis and intervention protocol", the patients in the control group received routine nursing care for delirium. The data of the study were collected using the Patient Identification Form, Acute Physiological and Chronic Health Evaluation, Glasgow Coma Scale, Richmond Agitation-Sedation Scale, Confusion Assessment Scale in the Intensive Care Unit, Nurse Diagnosis Form, Information Assessment Form for Postoperative Delirium (Pretest-Posttest) and Postoperative Delirium Prevention, Diagnosis and Intervention Protocol Checklist. In the first stage of the study, which consisted of three stages, the incidence of delirium in the control group patients receiving routine nursing care and the delirium diagnosis status of the nurses were determined. In the second stage, nurses were given training on postoperative delirium prevention, diagnosis and intervention protocol, and a preliminary study of the protocol was conducted. In the third phase, which is the last phase, patients in the intervention group received care in line with the "Postoperative Delirium Prevention, Diagnosis and Intervention Protocol". ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06268119
Study type	Interventional
Source	Mustafa Kemal University
Contact
Status	Completed
Phase	N/A
Start date	March 6, 2023
Completion date	May 22, 2023

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT06392308` - The Impact of Smoking on the Prognosis of Elderly Surgical Patients
Completed	`NCT06302517` - Bis Monitoring Effect on Delirium Occurrence and Nursing Quality Improvement Recovering From General Anesthesia	N/A
Recruiting	`NCT06090955` - Modulating Surgery-Induced Blood-Brain Barrier Disruption in Elderly	N/A
Recruiting	`NCT06052397` - Sleep and Circadian Rhythm Biomarkers of Postoperative Delirium
Not yet recruiting	`NCT06107517` - DREAMS-OT Trial: Delirium Reduction Through Early Activation in Motivating and Sleep Promoting Routines: A Randomized Controlled Trial of Occupational Therapy for ICU Patients After Coronary Artery Bypass Graft (CABG) Surgery	N/A
Completed	`NCT04563858` - Polish Validation 4AT Tool
Not yet recruiting	`NCT06268080` - Depth of Anesthesia on Postoperative Delirium and Cognitive After Surgery	N/A
Recruiting	`NCT06360549` - Effect of Percutaneous Acupoint Electrical Stimulation on Delirium	N/A
Completed	`NCT06187389` - Validation and Reliability of the Turkish 4AT Scale for Post-Anesthesia Awakening Delirium
Recruiting	`NCT01283412` - Dexmedetomidine on Postoperative Delirium and Quality of Recovery in Geriatric Patients	Phase 3
Recruiting	`NCT06318364` - Postoperative Delirium in the Post-anesthesia Care Unit
Recruiting	`NCT06318351` - Transcutaneous Acupoint Electrical Stimulation and Postoperative Delirium Delirium
Completed	`NCT01032161` - Perioperative Risk Factors for Postoperative Delirium in Children	N/A
Completed	`NCT05942183` - Optic Nerve Sheath Diameter is Associated With Postoperative Delirium in Patients Undergoing Open Heart Surgery
Not yet recruiting	`NCT06361238` - Liraglutide in Preventing Delirium in Diabetic Elderly After Cardiac Surgery	Phase 3
Not yet recruiting	`NCT06346990` - The Effect of Listening to Holy Quran Recital on the Incidence of Delirium Post-CABG	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.